Preclinical Studies of Vaccines for Pandemic H1N1 Influenza
大流行性 H1N1 流感疫苗的临床前研究
基本信息
- 批准号:8946487
- 负责人:
- 金额:$ 52.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Age DistributionAnimal ModelAntibody FormationAntiviral AgentsAttenuatedAvian Influenza A VirusBase SequenceBindingBirdsCaliforniaCell LineCell NucleusCell membraneCellsCenters for Disease Control and Prevention (U.S.)Cessation of lifeChildChildhoodComplexCytoplasmDataDevelopmentDiseaseDucksElderlyEngineeringEpidemicEpitheliumEventExposure toFamily suidaeFerretsFluorescent in Situ HybridizationGenesH1N1 vaccineHemagglutininHumanImmune responseImmunityIndividualInfectionInfluenzaInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H7N9 SubtypeInfluenza A virusIntestinesLeadLifeLightingLinkLower respiratory tract structureLungMediatingMembrane GlycoproteinsMicroscopyModelingMusMutationNatureNeuraminidaseNuclearNucleoproteinsPolymerasePolysaccharidesPopulationProteinsRNARNA TransportReportingRespiratory SystemRespiratory tract structureRiskRoleRouteSerumSialic AcidsSpecificitySpeedT cell responseTravelUnited StatesUpper respiratory tractVaccinatedVaccinationVaccinesViralViral GenomeViral HemagglutininsVirionVirulenceVirusWorld Health Organizationage groupaquatic birdbasecell fixingcell typedisorder preventioninfluenza outbreakinfluenzavirusmutantnovelpandemic diseasepandemic influenzapreclinical studypreferencereceptorreceptor bindingresponseseasonal influenzatissue tropismtransmission processviral RNAyoung adult
项目摘要
Infection by influenza viruses is mediated via binding of the viral surface glycoprotein hemagglutinin (HA) to terminally attached α2,3 or α2,6-linked sialic acids (SA) on cell surface glycoproteins. Avian influenza viruses predominantly bind to glycan receptors terminating in α2,3-linked SA while human-adapted viruses predominantly bind to glycan receptors terminating in α2,6-linked SA. Receptor-binding specificity is an important determinant of host-range restriction and transmission of influenza viruses. The distribution of SA in the human respiratory tract and duck intestine are thought to dictate the specificity of viruses infecting these two species. In humans, the epithelium of the upper respiratory tract primarily expresses α2,6 SA, while the lower respiratory tract (lung) contains both α2,3 and α2,6 SA. In contrast, avian species primarily express α2,3 SA in the cells lining the gut. Ferrets, a well-established animal model for influenza, have an α2,3 and α2,6 SA distribution similar to humans, while mice predominantly express α2,3 SA and little α2,6 SA. We assessed the role of receptor-binding preference of the viral HA on virulence and tissue tropism of the 2009 pandemic H1N1 (pH1N1) virus. The pH1N1 virus is known to predominantly bind to α2,6 SA and replicate well in the upper and lower respiratory tract of mice and ferrets. We generated two mutant viruses by engineering four mutations in the viral HA gene to alter receptor-binding preference. We found that the receptor specificity of the pH1N1 virus did not influence virulence in mice or viral replication in the respiratory tract of mice or ferrets. Additionally, we found that the WT, α2,6, and α2,3 pH1N1 viruses replicated in similar cell types in the lungs of ferrets. There is increasing evidence that receptor specificity of influenza viruses is more complex than the binary model of α2,6 and α2,3 SA binding and our data suggest that influenza viruses use a wide range of SA moieties to infect host cells.
Influenza A viruses, containing eight single stranded RNA segments, cause seasonal epidemics and occasional pandemics. Reassortment of the influenza viral genome in co-infected cells confers an evolutionary advantage for the virus, and can result in viruses with pandemic potential like the 2009 pandemic H1N1 and 2013 H7N9 virus. Replication of the viral genome occurs in the nucleus of the host cell and the progeny viral RNA (vRNA) segments must be transported to the plasma membrane for budding. The dynamics of vRNA assembly into progeny virions remains unknown. We used recent advances in microscopy to explore vRNA assembly and transport during a productive infection. We visualized four distinct vRNA segments within a single cell using fluorescent in situ hybridization (FISH) and observed that foci containing more than one vRNA segment were found at the external nuclear periphery, suggesting that vRNA segments are not exported to the cytoplasm individually. Although many cytoplasmic foci contain multiple vRNA segments, not all vRNA species are present in every focus, indicating that assembly of all eight vRNA segments does not occur prior to export from the nucleus. To extend the observations made in fixed cells, we used a virus that encodes GFP fused to the viral polymerase acidic (PA) protein (WSN PA-GFP) to explore the dynamics of vRNA assembly in live cells during a productive infection. Since WSN PA-GFP colocalizes with viral nucleoprotein and influenza vRNA segments, we used it as a surrogate for visualizing vRNA transport in 3D and at high speed by inverted selective-plane illumination microscopy. We observed cytoplasmic PA-GFP foci colocalizing and traveling together en-route to the plasma membrane. Our data suggest that vRNA segments are exported from the nucleus as subcomplexes that undergo additional assembly en-route to the plasma membrane through dynamic fusion events of vRNA-containing cytoplasmic foci. These observations have broad implications for understanding the intracellular requirements behind reassortment of influenza viruses and may lead to the development of new antiviral targets.
It has been suggested that the unusual age distribution of severe disease and death during the 2009 H1N1 pandemic, compared to seasonal influenza outbreaks, may at least be partly due to original antigenic sin (OAS). Unlike annual seasonal influenza infections where the elderly are at the greatest risk of suffering from severe disease and death, this age group was protected due to pre-existing immunity in the 2009 H1N1 pandemic, while severe disease and death predominated in young adults and children. It has also been suggested that the elderly, who were exposed during their childhood to viruses that were antigenically similar to the 2009 H1N1 virus, generated an antibody response against the viruses of childhood that cross-reacted with the 2009 pH1N1 virus. In contrast, younger individuals produced an antibody response against antigenically dissimilar influenza viruses from their childhood that failed to cross-react with the 2009 pH1N1 virus and diminished their response to the 2009 pH1N1 virus, resulting in more severe disease and death in this age group during the pandemic. To better understand the nature of the protection conferred by H1N1 viruses against subsequent exposure to the 2009 pH1N1 virus, we asked whether prior infection with older seasonal H1N1 influenza viruses would induce OAS upon subsequent infection with the 2009 pH1N1 virus. Evidence of OAS was sought using ferret sera. Ferrets were primed with H1N1 viruses of variable antigenic distance from 2009 pH1N1, and were challenged 6 weeks later with A/California/07/2009 wild-type (CA/09 wt) pH1N1 virus or were vaccinated with a monovalent live attenuated pH1N1 vaccine (CA/09 ca) or monovalent inactivated pH1N1 vaccine (CA/09 iav). In ferrets, seasonal H1N1 priming did not diminish the antibody response to infection or vaccination with the 2009 pH1N1 virus, nor did it diminish the T-cell response, indicating the absence of OAS in seasonal H1N1-virus primed ferrets. Our data from ferrets suggest that prior exposure to H1N1 viruses did not impair the immune response against the 2009 pH1N1 virus.
流感病毒的感染是通过病毒表面糖蛋白血凝素(HA)与细胞表面糖蛋白末端附着的α;2,3或α;2,6-链唾液酸(SA)结合介导的。禽流感病毒主要与终止于α;2,3-linked SA的聚糖受体结合,而人类适应病毒主要与终止于α;2,6-linked SA的聚糖受体结合。受体结合特异性是流感病毒宿主范围限制和传播的重要决定因素。SA在人类呼吸道和鸭肠中的分布被认为决定了感染这两个物种的病毒的特异性。在人类中,上呼吸道上皮主要表达α;2,6 SA,而下呼吸道(肺)同时含有α;2,3和α;2,6 SA。相比之下,鸟类主要在肠道内壁细胞中表达2,3 SA。雪貂是一种公认的流感动物模型,具有与人类相似的α;2,3和α;2,6 SA分布,而小鼠主要表达α;2,3 SA和少量α;2,6 SA。我们评估了病毒HA的受体结合偏好在2009年H1N1大流行病毒(pH1N1)的毒力和组织嗜性中的作用。已知pH1N1病毒主要与α;2,6 SA结合,并在小鼠和雪貂的上呼吸道和下呼吸道中复制良好。我们通过设计病毒HA基因的四个突变来改变受体结合偏好,从而产生了两个突变病毒。我们发现pH1N1病毒的受体特异性不影响小鼠的毒力或病毒在小鼠或雪貂呼吸道中的复制。此外,我们发现WT, α2,6和α;2,3 pH1N1病毒在雪貂肺中相似的细胞类型中复制。越来越多的证据表明,流感病毒的受体特异性比α;2,6和α;2,3 SA结合的二元模型更复杂,我们的数据表明流感病毒使用广泛的SA片段感染宿主细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kanta Subbarao其他文献
Kanta Subbarao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kanta Subbarao', 18)}}的其他基金
EVAL. OF VACCINE AGAINST HIGHLY PATHOGENIC INFLUENZA A(H5N1) VIRUS IN MACAQUES
评估。
- 批准号:
6940468 - 财政年份:2003
- 资助金额:
$ 52.54万 - 项目类别:
Preclinical Studies of Vaccines for Pandemic Influenza
大流行性流感疫苗的临床前研究
- 批准号:
7592290 - 财政年份:
- 资助金额:
$ 52.54万 - 项目类别:
Clinical Studies of Vaccines for Pandemic Influenza
大流行性流感疫苗的临床研究
- 批准号:
7592348 - 财政年份:
- 资助金额:
$ 52.54万 - 项目类别:
Preclinical Studies of Vaccines for Pandemic H1N1 Influenza
大流行性 H1N1 流感疫苗的临床前研究
- 批准号:
8745537 - 财政年份:
- 资助金额:
$ 52.54万 - 项目类别:
Vaccines, Immunoprophylaxis, and Immunotherapy for Coronaviruses
冠状病毒的疫苗、免疫预防和免疫治疗
- 批准号:
8946543 - 财政年份:
- 资助金额:
$ 52.54万 - 项目类别:
Clinical Studies of Vaccines for Pandemic Influenza
大流行性流感疫苗的临床研究
- 批准号:
8745450 - 财政年份:
- 资助金额:
$ 52.54万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 52.54万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 52.54万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 52.54万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 52.54万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 52.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 52.54万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 52.54万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 52.54万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 52.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 52.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists